AVEANNA HEALTHCARE HOLDINGS AVAH 深 沪
等待开盘 12-17 09:30:00 美东时间
8.84
-0.050
-0.56%
华盛通- 最 高8.99
- 今 开8.90
- 成交量 100.70万股
- 最 低 8.705
- 昨 收 8.89
- 总市值 18.21亿
- 52周最高 10.32
- 市盈率 静 --
- 换手率 0.49%
- 52周最低 3.67
- 委 比 -86.48%
- 总股本 2.06亿
- 历史最高 13.00
- 量 比 0.88
- 振 幅 3.21%
- 历史最低 0.6664
- 每 手 1
- 风险率 1.96%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多William Blair Initiates Coverage On Aveanna Healthcare Hldgs with Outperform Rating
William Blair analyst Jared Haase initiates coverage on Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Outperform rating.
12-08 22:29
Aveanna to Participate at the BofA Securities Home Care Conference
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) announced that its management team will virtually attend the BofA Securities Home Care Conference on December 9, 2025. Management will present at 12:30pm EST and host 1x1 investor meetings. A live webcast and replay will be available via the Company’s Investor Relations website. Aveanna, headquartered in Atlanta, Georgia, provides pediatric and adult healthcare services across 38 states, offering al...
12-04 22:00
美股大行评级 | 思科、On Holding、派拓网络等获多家机构上调目标价；Circle 遭富国、德银等多家机构下调目标价
今日重点评级关注：HC Wainwright & Co.：维持PDS Biotechnology"买入"评级，目标价从13美元升至15美元；HC Wainwright & Co.：维持PepGen Inc."买入"评级，目标价从18美元升至20美元
11-14 10:43
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
11-10 17:17
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
11-10 10:22
Aveanna Healthcare Highlights Strong Financial Performance
Aveanna Healthcare Holdings ( ($AVAH) ) has shared an announcement. On November...
11-07 20:48
Aveanna Healthcare Holdings shares are trading lower. The company reported Q3 financial results.
Aveanna Healthcare Holdings shares are trading lower. The company reported Q3 f...
11-06 21:54
Aveanna Healthcare Hldgs Sees FY2025 Sales Greater Than $2.375B vs $2.328B Est, Updated From Greater Than $2.3B
Full Year 2025 GuidanceThe following is our guidance reflecting our updated expectations for revenue and Adjusted EBITDA for the full fiscal year 2025 (year ending January 3, 2026):Revenue of greater than $2.375 billion,
11-06 19:33
Earnings Scheduled For November 6, 2025
Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...
11-06 19:12
美股大行评级 | 上调！苹果、亚马逊、Amkor Tech、Cadence、Confluent、卡特、通用动力等获多家上调目标价
今日重点评级关注：HC Wainwright & Co.：维持PepGen"买入"评级，目标价从12美元升至18美元；Piper Sandler：维持Prothena Corp"超配"评级，目标价从15美元升至36美元
10-29 09:25
